Bid Banana
PricingBid helpAPILog inStart free trial
Log inStart free trial

Before you respond

  • Federal grantsHow to Find Grants for Nonprofits
  • Healthcare RFPsHealthcare and Medical Services Bids and Bidding Guide
  • How to apply for a grantGrant Applications vs. RFPs: Writing Differences Explained
More healthcare and medical services bids →Must-win bid? Bring in The Bid Lab →
Bid Banana
SearchPricingBid helpBrowse bidsAPISupportFAQPrivacy PolicyTerms of UseAI Use Policy

This website and its content is copyright of The Bid Lab © 2026. The Bid Lab is a trademark of Bid Lab, LLC. All rights reserved.

  1. Bid Banana
  2. ›Bids
  3. ›Federal
  4. ›OMHHE Educational Funding Opportunity: Expanding education…

U.S. Food and Drug Administration·United States of America

OMHHE Educational Funding Opportunity: Expanding education on skin lightening products (U01) Clinical Trials Not Allowed

Rolling / TBD close$250kGrants Notice
Get bids like this by emailBid source

Description

The Food and Drug Administration (FDA) is seeking applicants for a funding opportunity to expand education on skin lightening products containing hydroquinone and/or mercury. The goal of this project is to research and propose innovative, community-based strategies for public awareness and education on the potential risks associated with these products. Applicants will be expected to develop and implement effective strategies to strengthen the science base for education and public health awareness. Some key aspects of this opportunity include: • Expanding FDA's Office of Minority Health and Health Equity (OMHHE) work with stakeholders and partners • Developing community-based strategies for public awareness and education • Strengthening the science base for education and public health awareness on skin lightening products • Collaborating with stakeholders and partners to achieve project goals

Attached files

The solicitation documents live at the source — open the bid source above to download them.

Contact

Terrin Brown(Grantor)

[email protected]

(240) 402-7610

Key dates

Opened
12/12/2023
Closes
Rolling / TBD
Projected award
6/1/2026
Duration
4 years

Last updated

Details

Type
Grants Notice
Industry
Healthcare and Medical Services
NAICS
541720
Solicitation №
FOR-FD-24-017

Budget estimate

$250,000

The Award Floor and Ceiling are explicitly stated on the source site.

Similar opportunities

Matched by Bid Banana AI™

Bid Banana · 1.6M+ bids and awards 🍌

You found this one. Bid Banana has 1.6M+ bids and awards.

You found this bid by looking. Bid Banana searches open government bids across all 50 states, updated daily, so you stop hunting: save a search once and we email you your new matches, daily or weekly.

1.6M+
bids & awards
All 50
states
4,000+
agencies
Start your 7-day free trial

Plans from $49.99/month. Cancel anytime, no setup fees.

Built by The Bid Lab, answering RFPs since 2017.

U.S. Food and Drug Administration·United States of America

Top match · 94%

Educational Funding Opportunity: Expanding education on skin lightening products (U01) Clinical Trials Not Allowed

Rolling / TBD closeOpened 8/14/2024

U.S. Food and Drug Administration·United States of America

85% match

FDA OMHHE Health Equity Innovation Award: Enhance Equity Funding Opportunity (U01) Clinical Trials Not Allowed

Rolling / TBD closeOpened 12/8/2023

U.S. Food and Drug Administration·United States of America

81% match

Health Equity Innovation Award: Enhance Equity Funding Opportunity (U01) Clinical Trials Not Allowed

Rolling / TBD closeOpened 8/14/2024

U.S. National Institutes of Health·United States of America

80% match

CCRP Initiative: Promoting a Basic Understanding of Chemical Threats to Skin (R01 Clinical Trial Not Allowed)

Closes 11/5/2028Opened 6/30/2025

U.S. National Institutes of Health·United States of America

80% match

Limited Competition: CCRP Initiative: Promoting a Basic Understanding of Chemical Threats to Skin (R34 Clinical Trial Not Allowed)

Closes 1/7/2028Opened 10/4/2024

U.S. Administration for Children and Families-IOAS-OTIP·United States of America

80% match

Human Trafficking Youth Prevention Education (HTYPE) Demonstration Program

Closes 4/8/2027Opened 8/31/2026

U.S. Food and Drug Administration·United States of America

80% match

REACHing Communities (REACH) Consortium (U01) Clinical Trials Optional

Rolling / TBD closeOpened 8/14/2024

U.S. Food and Drug Administration·United States of America

80% match

Efficient and Innovative Natural History Studies Addressing Unmet Needs in Rare Diseases (R01 Clinical Trials Optional)

Rolling / TBD closeOpened 7/11/2025

U.S. Food and Drug Administration·United States of America

80% match

Identification and Evaluation of Possible Approaches to Addressing Nitrosamine Impurities in Drugs (U01)

Rolling / TBD closeOpened 11/24/2023

U.S. National Institutes of Health·United States of America

79% match

Limited Competition: Supporting Programs to Advance Research Knowledge in Environmental Health Sciences (SPARK-EHS) (UE5/T32 - Clinical Trial Not Allowed)

Closes 12/6/2026Opened 6/26/2026

U.S. National Institutes of Health·United States of America

79% match

Bioengineering Partnerships with Industry (U01 Clinical Trial Optional)

Closes 9/7/2027Opened 3/8/2022

U.S. Food and Drug Administration·United States of America

79% match

Reducing Fraud and Lowering Barriers to the Production of Drugs in Shortage by Outsourcing Facilities

Rolling / TBD closeOpened 7/21/2025

U.S. National Institutes of Health·United States of America

79% match

Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Not Allowed)

Closes 1/7/2028Opened 3/25/2021

U.S. Food and Drug Administration·United States of America

79% match

Studies Addressing Rare Neurodegenerative Diseases including ALS

Rolling / TBD closeOpened 8/14/2024

U.S. National Institutes of Health·United States of America

79% match

Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Neurotherapeutic Agent Identification (R61/R33 Clinical Trial Not Allowed)

Closes 10/20/2027Opened 10/22/2024

U.S. National Institutes of Health·United States of America

79% match

Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Development and Validation of Model Systems to Facilitate Neurotherapeutic Discovery (R61/R33 Clinical Trial Not Allowed)

Closes 10/20/2027Opened 10/22/2024

U.S. Food and Drug Administration·United States of America

79% match

Clinical Trials Addressing Unmet Needs of Rare Neurodegenerative Diseases (R01) Clinical Trials Required

Rolling / TBD closeOpened 8/14/2024

U.S. National Institutes of Health·United States of America

79% match

NCCIH Natural Product Early Phase Clinical Trial Phased Innovation Award (R61/R33 Clinical Trial Required)

Closes 11/13/2026Opened 2/1/2024

U.S. Food and Drug Administration·United States of America

78% match

Flexible Funding Model-Infrastructure Development and Maintenance for State Manufactured Food Regulatory Programs (U2F) Clinical Trials Not Allowed

Rolling / TBD closeOpened 11/24/2023

U.S. Food and Drug Administration·United States of America

78% match

Collaborations to Enhance Drug Development and Regulatory Science

Rolling / TBD closeOpened 11/30/2023

U.S. Food and Drug Administration·United States of America

78% match

Reissue of RFA-FD-22-001 - Efficient and Innovative Natural History Studies Addressing Unmet Needs in Rare Diseases (R01 Clinical Trials Optional)

Closes 2/8/2028Opened 7/11/2025

U.S. National Institutes of Health·United States of America

78% match

Limited Competition: NIMHD Initiative for Improving American Indian and Alaska Native Cancer Outcomes (U19 - Clinical Trial Optional)

Closes 1/24/2027Opened 7/16/2026

U.S. National Institutes of Health·United States of America

78% match

Cancer Research Education Grants Program - Courses for Skills Development (R25 Clinical Trial Not Allowed)

Closes 1/7/2027Opened 9/29/2023

U.S. National Institutes of Health·United States of America

78% match

Development of Models, New Approach Methodologies, and Biological Materials for Studying Human Health and Diseases (R21 Clinical Trial Not Allowed)

Closes 2/15/2028Opened 9/16/2026

U.S. National Institutes of Health·United States of America

78% match

Cancer Prevention and Control Clinical Trials Planning Grant Program (R34 Clinical Trials Optional)

Closes 10/25/2027Opened 6/23/2022